According to the distribution stage, Braak et al. proposed that Tau pathology to be divided into six different stages, which are closely related to the severity of cognitive impairment and neuronal loss of patients with AD (Chung et al., 2021; Roda et al., 2022). The gene discussed is MAPT; the disease is Cognitive impairment.